Skip to content
healthcare.dev

UPTRAVI

NDC 66215-614, Selexipag, tablet, coated, from Actelion Pharmaceuticals US, Inc..

Product NDC
66215-614
Status
Listed
Labeler
Actelion Pharmaceuticals US, Inc.
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207947
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66215-614 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELEXIPAG1400 ug/1

Pharmacologic classes

Prostacyclin Receptor Agonist [EPC]; Prostacyclin Receptor Agonists [MoA]

Package NDCNDC-11Package
66215-614-06662150614061 BOTTLE in 1 CARTON (66215-614-06) / 60 TABLET, COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a7a23b87-f892-4e2c-8e2e-ebf841220f90

Use it

Look up 66215-614 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66215-614 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66215-614. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.